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Objective: This study sought to determine the spectrum of electrocardio-
graphic (ECG) abnormalities found in patients with primary systemic amyloi-
dosis (AL), senile systemic amyloidosis (SSA) and Transthyretin-Related
Amyloidosis (TTR) and to evaluate the prognostic implications. 
Methods: Between 2010 and 2012, 103 patients treated in the University
Henri-Mondor Hospital with cardiac amyloidosis were included. 32 patients
with AL, 63 patients with TTR and 11 patients with SSA. ECG were analysed
regarding: rhythm, conduction, voltage, and ischaemic signs. The primary
endpoint was defined as death or heart transplantation.
Results: The mean age and men prevalence were respectively 62±15 and
64%. Atrial fibrillation was significantly more frequent (p=0.005) in the SSA
group (44%) compared to AL group (13%) and TTR group (7%). No significant
difference was found between the three groups when low voltage was defined
according to the Klein criteria or defined as a voltage inferior to 1 mV in all
precordial limbs. But when it was defined as a voltage <0, 5 mV in all limb
leads it was found significantly higher (p=0.006) in the AL population (36%)
compared to the TTR (8%) and SSA (25%) groups. LV hypertrophy was rare in
the three groups. No significant difference was found concerning conduction
disorders (p=0.064) and the presence of Q waves (61% AL, 51% TTR, 33%
SSA, p=0.51) or reduced R wave height (7% AL, 20% TTR, 0% SSA, p=0.14). 
Conclusion: Electrocardiographic abnormalities are frequent in amyloi-
dosis whatever the type.
077
Midventricular Takotsubo cardiomyopathy: clinical characteristics
and prognosis.
Frédéric Moulin, Zied Frikha, Batric Popovic, Etienne Aliot, Olivier Huttin,
Michael Angioi
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Background: Takotsubo cardiomyopathy was initially described as apical
ballooning with apical wall motion abnormalities. A group of patients pre-
senting with atypical appearence with mid-ventricular wall motion abnor-
mality was also described, but the incidence, the clinical characteristics and
the prognosis of this pattern have not yet been assessed.
Objectives: The aim of our study is to analyse the clinical profile, demo-
graphic characteristics and outcomes of patients with mid-ventricular Takot-
subo cardiomyopathy (TC).
Methods: A retrospective monocentric study enrolling fifty-six subsequent
patients hospitalised for TC, between January 2002 and January 2013. Only
patients with mid-ventricular form are included.
Results: The incidence of the midventricular form was 25% (14 patients).
The wall motion abnormalities in these patients were confirmed by both left
ventriculogram and cardiac magnetic resonance. The mean age was 65±10
years. Hypertension and dyslipidemia were the most common risk factors for
coronary heart disease (64.3% and 35.7% respectively). A history of cancer was
noted in 35.7%. A stressful event preceded presentation in 11 patients (78.6%).
Chest pain was the most common symptom (85.7%). Global T wave inversion
was the most frequent electrocardiographic changes (64.3%). The peak troponin
levels was 2.6±3.2 ng/ml. Mean left ventricular ejection fraction at initial pre-
sentation was moderetly impaired (45.5±9%). In-hospital mortality was 7% and
no other in-hospital complication was occurred. After a mean follow-up of
50±30 months, overall mortality, cardiovascular hospitalization and recurrence
were noted respectively in 15.4%, 46.2% and 7% of cases.
Conclusions: Our study demonstrated that midventricular takotsubo cardio-
myopathy is associated with significant  long term morbidity and mortality.
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Heart failure secondary to dilated cardiomyopathy: the correlation
between mechanical and electrical dyssynchrony: about 61 cases 
Sana Sioua, Sana Fennira, Saoussen Antit, Mohamed Habib Khaldi,
Sondos Kraiem
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Introduction: The existence of an abnormal electrical activation of the
myocardium is a common feature in the case of dilated cardiomyopathy. This
can lengthen the time of ventricular contraction and generate electro anoma-
lies affecting the contraction and the relaxation of the left ventricle.
Material and results: We conducted a prospective study of 61 patients with
heart failure secondary to dilated cardiomyopathy. This study aims to analyze
the correlation between electrocardiographic parameters and mechanical dyssyn-
chrony ( inter and intraventricular dyssynchrony).We found that 95% of patients
with complete left bundle branch block (BBGC) had whether inter or intraven-
tricular dyssynchrony. Among the patients with a BBGC, the number of those
with an interventricular dyssynchrony was equal to that of those with an intra-
ventricular dyssynchrony (23%). One hundred percent of our patients with a
QRS duration > 140 ms had whether an inter or an intraventricular dyssyn-
chrony.Inter or intraventricular asynchrony was also present in 45% of our
patients with a QRS duration ≤ 120ms. In this population, the prevalence of the
intraventricular dyssynchrony was higher than that of the interventricular one.
We found a statistically significant positive correlation between the QRS dura-
tion and the parameters of interventricular dyssynchrony in echocardiography
Doppler: Aortic pre-ejection delay (p<10-3) with an interval between the Aortic
and the Pulmonary pre-ejectionnel ( p<10-3).We also noted a statistically signif-
icant positive correlation  (p<10-3) between the QRS duration and the intraven-
tricular dyssynchrony measured by the Doppler echocardiography maximum
interval between electro-systolic delays.
Conclusion: The study demonstrates a significant association between
the prolonged QRS duration and the mechanical dyssynchrony. As a
matter of fact, nowadays , indicating a multisite pacemaker is based pri-
marily on the electrocardiographic criteria of dyssynchrony in the case of
an absence of an individualized reproducible criterion of the mechanical
dyssynchrony.
079
New prognostic factors in heart failure with preserved ejection frac-
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KaRen was a prospective multicentre study identifying predictors of out-
come in patients with Heart Failure and preserved Ejection Fraction (HFpEF),
with a special focus on electrical and mechanical dyssynchrony
Method: 539 patients were included following an acute HF presentation
accompanied with BNP> 100 pg/mL or NT-proBNP>300 pg/mL and LVEF
>45%. 438 patients were reassessed after 4 -8 weeks. ECG (18 variables) and
echo (117 variables) were analysed in core centres. Patients were followed
during a minimum of 18 months. The primary endpoint was time to all-cause
death or first HF hospitalisation. 
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Patients: The mean age was 76± 9 years and 57% were women. A history
of HF was found in 40.4%. Patients´ history included hypertension in 78.5%,
atrial tachyarrhythmia in 58%, anemia (Hb<12mg/dL in females and 13mg/dL
in males) in 47.2%, diabetes in 31.3%, renal dysfunction in 37.9%, coronary
artery disease in 28% and COPD in 12.3%. Of the patients 6.1% had first
degree AV block and 14.9% had QRS width > 120 ms. 
Results: During a mean follow-up time of 21.6 months a primary outcome
event occurred in 204 patients (46.5%), consisting of 101 deaths (23%) and 142
HF-hospitalizations (32.5%). Candidate predictors of outcome are presented in
Figure 1. First degree AV block was the only dyssynchrony criteria independently
predicting outcome (p=0.04) 2- tricuspid regurgitation (mean±standard devia-
tion=2.87±0.64 m/s, p=0.0009) and mean e’ velocity >5.5cm/s (mean±standard
deviation=7.95±2.58, p=0.0009) were the two echocardiographic predictors.
Ongoing ACE (ARB) treatment was the only positive predictor of outcome. 
Conclusion: The KaRen study recruited a representative population of HFpEF
patients with a high rate of clinical events (23% deaths).First degree atrio-ventric-
ular block and increased pulmonary arterial pressures and left ventricular diastolic
dysfunction were independently associated with outcome. These novel data may
provide new information improving the management of HFpEF patients. 
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Genetic background of multifactorial systolic heart failure (systHF) is still
poorly understood. However, through a recent genome wide association study
we identified two loci significantly associated with sporadic Dilated Cardio-
myopathy (DCM): BAG3 and HSPB7 loci. We further studied these two loci
and hypothesized (1) that the loci could also be involved in systHF due to cor-
onary artery disease (CAD) and (2) that the loci could be involved in the
severity of systHF and not only in the susceptibility to develop HF.
Methods. We genotyped polymorphisms (SNPs) previously associated
with DCM (rs2234962 for BAG3 locus, rs10927875 and rs945417 for HSPB7
locus) in a European population of 1160 patients with systHF due to CAD
(ischemic-HF) and 1322 controls. The severity of systHF (assessed by left
ventricle ejection fraction or LVEF, LV end diastolic diameter or LVEDD,
age and NYHA dyspnea at inclusion) was also compared according to the
SNPs in the cohort of ischemic-HF patients as well as in a European cohort of
1141 patients with DCM.
Results. We observed that SNPs related to HSPB7 locus were significantly
associated with ischemic-HF (MAF of rs10927875 and rs945417 were less
frequent in patients than controls, adjusted p value 0.0.0017 and 0.0.0016
respectively) whereas SNP related to BAG3 locus was not. In cohorts of
patients with ischemic-HF or DCM, the two loci were not associated with
severity of HF, except LVEDD that was significantly associated with
rs2234962 (BAG3 locus) both in DCM patients (591 patients with LVEDD
available) and ischemic-HF patients (348 patients with LVEDD available)
(p=0.0086 and 0.012 respectively).
Conclusions. Out of the two loci previously associated with DCM we
observed that HSPB7 locus was also associated with ischemic-HF whereas
BAG3 locus was not, suggesting differential involvement according to the
underlying cause of HF. Severity of HF was not related to the two loci, except
BAG3 locus associated with LV diameter in both populations. 
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associated factors.
Tounsi Ahmed, Jerbi Bassem, Abid Leila, Mallek Souad, Akrout Malek,
Hentati Mourad, Kammoun Samir
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Chronic heart failure (HF) and erectile dysfunction (ED) are 2 highly prev-
alent disorders that frequently occur concomitantly. ED has a significant effect
on patients' quality of life. The aim of this study was to investigate the prev-
alence and factors associated with erectile dysfunction in systolic heart failure.
Methods: In a cross-sectional study 110 male patients (age=58.2+-9.7
years) with systolic heart failure (LVEF<=45%) were selected using
convenience sampling method. IIEF-5 questionnaire (the International
Index of Erectile Function, 5-item version), were used to evaluate the pres-
ence and the severity of ED. Baseline clinical characteristics known to be
associated with ED, such as NYHA functional classification, were also
documented.
Results: The prevalence of ED was found to be 69.1%. Mean score of erec-
tile dysfunction was 19.24±4.08. Erectile dysfunction was significantly associ-
ated with age (P<0.001), diabetes mellitus (P= 0.007), low left ventricular
ejection fraction (P=0.03), renal dysfunction (P=0.01), angiotensin converting
enzyme inhibitors (P= 0.03), beta blocker (P=0.01), diuretics (P=0.05).
Conclusion: Physicians should be aware of the close relation between HF
and ED and of the related clinical and therapeutic implications, in order to
improve patients quality of life and clinical outcome.
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Therapeutic education and recent acute heart failure: the two keys for
a successful telemonitoring program in heart failure. Systematic
review and meta-analysis of randomized clinical trials.
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Aims: We hypothesized that long term educational support and recent hos-
pitalization for acute HF could influence the results of telemonitoring (TM)
programs in heart failure (HF).
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Methods: We conducted a meta-analysis of randomized clinical trials to
compare the effectiveness of TM programs with or without long term thera-
peutic education in patients with or without recent acute HF hospitalization.
The primary endpoint was all-cause mortality. Secondary endpoints included
hospitalization for acute HF and all-cause hospitalization.
Results: We sampled 18 trials, representing a total of 5,653 patients. Overall,
TM reduced the risk of all-cause mortality (OR=0.79; 95% CI=0.67 – 0.94) and
the risk of acute HF hospitalizations (OR=0.2 95% CI=0.71 – 0.94). TM pro-
grams with long term educational support reduced all-cause mortality
(OR=0.61; 95% CI=0.46 – 0.81) whereas those without did not (OR=0.92;
95% CI=0.74 – 1.14). TM programs dedicated to patients with recent acute
HF decreased the risk of all-cause mortality (OR=0.70; 95% CI=0.57 – 0.87),
whereas those including stable ambulatory patients did not (OR=1.00; 95%
CI=0.74 – 1.34). The association between “recent acute heart failure” and
“therapeutic education” led to the best results. Results concerning acute heart
failure hospitalizations were similar.
Conclusion:  TM programs significantly reduced the risk of all-cause mor-
tality and the risk of hospitalization for acute HF. The patients of the subgroup
“with recent acute HF” and “with therapeutic education” seem to be the best
responders to the system (table above).
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Aim: Therapeutic patient education (TPE) seems to be comprehensive care
provided to the patient. We deemed it necessary to question heart failure
patients’ perception on this approach. This survey aims at assessing the TPE
program impact on the patient’s life.
Methods: An auto-administered survey was conducted between January
and May 2013. We addressed the survey to patients listed in the ODIN reg-
ister created to observe heart failure allowing us to have a closer look at the
mortality of educated and non educated patients. A total of 2397 question-
naires were distributed permitting anonymous answers. Ethical national
committee gave the approval.
Results: In May 2013, we received 257 answers. Respondents were men
(72.3%) aged around 67 years old (sd. 12, 7). Respondents received TPE in
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63.81% of the cases. They felt like having received enough TPE sessions
(50.2%) and wished to continue TPE (36.2%).They considered TPE as a
means to adapt their lives to their sickness (29.2%) and an opportunity to
receive comprehensive information on heart failure and treatments
(27.6%). They felt progress in their daily lives (59.1%) and said they cope
better with their sickness (44.7%). In 53.3% of the cases, they recognized that
this process was beneficial compared to a traditional care management. They
noticed progress in their relationship with their doctor in more than 31.9%.
Conclusion: The survey shows that, to responding patients, TPE has had a true
impact on IC patients' life plan and on the traditional care relationship. Patients
talked about a positive change in their daily habits such as a healthier lifestyle both
in terms of food and physical activity. They felt less tense, more confident and
they said they lived better with their condition. TPE also improves the relationship
between patients and health professionals since patients no longer felt put aside.
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Objectives: Left Ventricular Assist Devices (LVAD) are commonly used
to assist failing hearts as a bridge to transplantation or for long-term support.
The purpose of the MESenchymal stem cell (MSC) therapy and LVAD
(MESAD) program is to improve heart function with stem cell therapy and
attempt to wean patients from HeartMate II LVAD (HMII). 
Methods: Currently LVAD-only patients are being implanted and fol-
lowed. Feasibility of autologous MSC grafting in patients receiving HMII will
be assessed in a 4 patient pilot trial. MSC are delivered during LVAD surgery
by intramyocardial infusions. Recovery of contractile function of the heart is
assessed during attempts to wean patients from LVAD.
Results: Up to March 2013, 26 heart failure patients successfully implanted
with the HMII LVAD have been followed. Main baseline characteristics are:
mean age 56 yrs, 79% males, mean EF of 21%, 75% ischemic heart failure.
During the follow-up 6 patients died, 1 patient was transplanted and no patient
explanted for recovery. Our 180-days survival rate is 89%. The pilot trial with
MSC is in the approval process and expected to begin in Q3 of this year. 
Conclusion: Mechanical circulatory support provided by the HMII LVAD
shows great results and may allow the left ventricle to rest and recover enough
so that removal of the device is possible and a heart transplant is no longer
needed or may decrease the risk of complication in very long term destination.
Combining both HMII and MSC might be promising for the future of severe
heart failure management. 
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Beta-blockade with bisoprolol in heart failure patients with right ven-
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Beta-blocker use improves left ventricular ejection fraction (LVEF) in patients
with heart failure. A similar effect of beta-blockers on right ventricular function
has been proposed, although the effect of bisoprolol on right ventricular function
has not been assessed. This study investigated the short-term effect of bisoprolol
on right ventricular function in chronic heart failure patients. A cohort of 60 heart
failure patients who were not taking beta-blockers at baseline was studied prospec-
tively. Right ventricular ejection fraction (RVEF) and LVEF were measured at
both baseline and 6 months by echocardiography. Various parameters of the right
ventricular function were measured: Simpson RVEF, surface shortening fraction,
right ventricular outflow tract (RVOT%), TAPSE (mm), S’ wave with tissue dop-
pler (cm/s), and the Tei index. The threshold of significativity was fixed at 5%.
Bisoprolol was up titred during six months by a preestablished protocol to a target
dose of 10 mg/d. Mean age was 65.7±16.3 years. Baseline RVEF was 25.6±5.2%
and baseline LVEF was 20.8±6.4%. Mean bisoprolol dose reached was 5.1±3.7
mg daily. At 12 months, RVEF was significantly increased by 7.5% (95% confi-
dence interval, 3.9–10.2; P=0.0001) and LVEF also increased significantly by
7.5% (95% confidence interval, 4.0–11.9%; P=0.0003). All the parameters of the
right ventricular function were significantly improved: TAPSE (15.5 vs 12.7;
P=0.078), S’ (10.7 vs 8.2; P=0.002), Tei index (54.10 vs 81.45; P=0.0008,
RVOT% (27.1 vs 19.3; P=0.036), dp/dt RV (721 vs 505; P=0.05). Bisoprolol
treatment for 6 months resulted in a significant improvement of right ventricular
function in chronic heart failure.
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Impact of recipient’s age on long-term outcomes after heart trans-
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Sarah Cohen (1), Shaida Varnous (2), Nicolas Danchin (1), Alain Pavie (2)
(1) Hôpital Européen Georges Pompidou (HEGP), Paris, France –
(2) Hôpital La Pitié-Salpêtriere, Paris, France
Background: Heart transplantation (HTx) is considered as the treatment
of choice for patients with end-stage heart failure. Over the last few years
significant changes have occurred in candidate profiles for HTx.  Advanced
age has been viewed as a contraindication to HTx. We analyzed the effect of
recipient's age on HTx outcome in a large cohort of recipients. 
Methods: Between January 2005 and June 2009, 81 patients aged
≥60 years (mean, 64±3.5 years) underwent HTx at our institution. They were
compared with 217 adult recipients <60 years (mean, 46 ±11 years) who
underwent HTx during the same period.
Results:The mean follow-up was 42 months [0-94]. Patients in the elderly
group were more often males (90.1% vs 74.2%, p=0.003), had a higher body
mass index (26.1 kg/m² vs 24.2 kg/m², p=0.006), higher serum creatinine
levels (128 μmol/L vs 107 μmol /L, p=0.003), higher proportion of diabetes
mellitus (24.7% vs 14.3%, p=0.034) and undergone cardiac resynchronization
therapy more frequently (27.2% vs 14.7%, p=0.013). No significant differ-
ences were found regarding donor age (46.5 vs 46.3 years), cardiac allograft
ischemic time (181 vs 183 min) or cause of death. Thirty-day mortality was
24.8% for the entire cohort, and 35.8% vs 20.7% (p=0.01) for the older and
younger patients, respectively. Long-term survival was significantly worse in
the elderly group (Figure). The excess mortality in the elder patients mainly
occurred during the first year following HTx (48.2% vs 24.9%, p<0.001).
Recipient age (HR=1.032; 95% CI[1.002-1.063]; p=0.034) and serum creati-
nine level (HR=1.01; 95% CI[1.005-1.016]; p=0.001) were independent pre-
dictors of mortality by multivariate analysis. 
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Conclusion: In the present study, recipient age after HTx was associated
with lower early and late survival. Pre-operative serum creatinine was also
predictive of death. The decision to offer HTx to patients aged ≥60 years
should be considered cautiously. 
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Impact of sex mismatch on overall and cardiac survivals in male heart
recipients: a 21-year French experience
Emmanuelle Vermes (1), Agnes Sirinelli (2), Jean Frederic Marliere (2),
Alain Mirza (2), Christian Mirguet (2), Michel Aupart (2)
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Trousseau, Chirurgie Cardiaque, Chambray Les Tours, France
Background: The purpose of the present study was to analyze the impact
of sex mismatch on long-term survival in male heart recipients.
Methods: We reviewed data of 189 male patients who underwent primary
heart transplantation at a single center between 1991 and 2012. Survival of
male recipients with female donors (F/M group=43 patients) was compared to
that of male recipients with male donors (M/M group=146 patients). Causes
of mortality were analyzed and divided into 3 categories: cardiac (acute rejec-
tion, cardiac allograft vasculopathy or sudden cardiac death), cancer and other.
Results: A total of 52 patients died over 21 year follow up: 15 patients
(35%) in F/M group; 37 patients (25%) in M/M group. Overall survival rate
was significantly lower in F/M group (p< 0.0187) [figure 1].
Differences between F/M and M/M groups started early after transplant and
increased over time; survival rate at 1 year was 88% vs 93%, at 5 years was 72%
vs 87% at 10 years was 54% vs 72% respectively. In multivariate analysis including
graft ischemic time, differences between donor/ recipient height >10%, between
donor/ recipient age > 5 years, pulmonary resistance >3 UW and emergency status;
sex mismatch was the only predictor of mortality (p=0.0376, HR 2.2, 95% CI 1.04-
4.66). Cardiac cause was the most common causes of mortality (21 patients;
8 patients in F/M group and 13 patients in M/M group), 14 patients died of cancer.
Cardiac survival rate was significantly lower in F/M group (p<0.0143) 
Conclusion: Sex mismatch in male heart recipients leads to lower short
and long term overall and cardiac survivals.
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Dagorn (1), Michel Desnos (3), Yves Juillière (4), Daniel Decup (5), Gerald
Roul (6)
(1) CH René Dubos, UT d’insuffisance cardiaque, Pontoise, France –
(2) CH René Dubos, Service de cardiologie, Pontoise, France – (3) Hôpi-
tal Européen Georges Pompidou (HEGP), Paris, France – (4) Nancy
University Hospital, Department of Cardiology, Vandoeuvre-Lès-Nancy,
France – (5) CH René Dubos, Department of medicoeconomic analysis,
Pontoise, France – (6) CHU Strasbourg, Service de cardiologie, Stras-
bourg, France
CHF is a severe disease. Most of prognostic scores focusing on long term
follow up. On the opposite of acute heart failure scores, there is no real score
that could be used by clinicians in order to analyzed the short term risk of
short term (6 months) re-hospitalization or death. 
We have analyzed the prognostic performance of clinical biological
data in a prospective cohort of 1310 CHF patients. The events taken in
account should be before the next planned out patient hospitalization
(6 months).
Our patients were mostly young (men Age 63 years old ), 70% were in
sinus rhythm, 10% demonstrate clinical congestion (lower limb oedema).
Mean LVEF was 36% (± 10). HF aetiology was dilated in 50% and isch-
aemic in 40% of patients. During follow up 387 events (death or HF hospi-
talizations) occured. In our cohort, heart rate, weight variation, NYHA class
variation, BNP absolute value (<200, 200-500 and > 500 pg/ml) and BNP
variation were statistically associated with a risk  of events. We have created
a simple score (5 to 11 points) associating these parameters that is closely
related to short term risk post clinical examination (less than 5% to more
than 27% risk).
Conclusion: A simple score could help clinicians to analyse the short term
risk of death and hospitalization in CHF patients. This could be useful in order
to target high risk sub groups of patients that could benefit from an enhanced
follow up or more aggressive management.
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Prevalence of mechanical dissynchrony in heart failure patients accor-
ding to QRS width
Leila Bezdah, Wafa Faleh, Emna Allouche, Saoussen Antit, Amine
Marouène, Hédi Baccar
Hôpital Charles Nicolle, Cardiologie, Tunis, Tunisie
Introduction: Cardiac resynchronization therapy (CRT) has emerged as an
established therapy for congestive heart failure (CHF). However, up to 30%
of patients fail to respond to CRT despite prolonged QRS and some other
patients respond to CRT despite thin QRS.
The aim of this study is to define the prevalence of mechanical (atrio-
ventricular, interventricular and intraventricular) dissynchrony in heart failure
patients with different QRS durations.
Methods: A total of 46 patients with heart failure (dilated
cardiomyopathy  with LVEF <40%, NYHA II-IV) were prospectively eval-
uated using 12-lead electrocardiogram and complete echocardiographic
examination including tissue Doppler imaging. All the patients had sinus
rhythm and the dilated cardiomyopathy was primitive in 37% of patients and
ischemic in the others.
Results: According to QRS duration, 16 patients had QRS ≥150ms
(group 1), 15 patients had QRS duration between 120 and 149 ms (group 2)
and 15 patients had QRS duration <120 ms (group 3). Interventricular dyssyn-
chrony (IVD) was present in 62% of group 1, 13% of group 2 and was absent
in group 3 (p<0,001). Intraventricular dyssynchrony (IntraVD) was present
respectively in 94%, 40%, 20% of groups 1,2, and 3 (p<0,001). However,
there was no significant difference in the prevalence of atrioventricular dys-
synchrony (AVD) between the three groups. A multiparametric approach by
focusing on criteria combination found that the association of IVD + IntraVD
+ AVD was present only in group 1 and  the combination of two criteria was
seen  only in group 1 and 2 with a significantly higher prevalence in group 1
(p<0,01).
Conclusion: The prevalence of mechanical dissynchrony increases with
the increasing QRS duration and the combination of criteria is significantly
more prevalent when the QRS width is ≥150 ms. 
Intraventricular dissynchrony can be observed in heart failure patients with
a narrow QRS complex and may be useful in predicting left ventricular
reverse remodeling after CRT.
The lack of dyssynchrony in some patients with standard CRT indication
by QRS duration may sometimes explain the non responder’s rates.
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Assessment of patient personality in Tako-Tsubo cardiomyopathy 
Nicolas Mansencal (1), Edouard Gerbaud (2), Denis Doyen (3), Nathalie
Lesavre (4), Erwan Donal (5), Pascal Motreff (6), Patrick Meimoun (7),
Grégory Ducrocq (8), Olivier Nallet (9), Alexandre Founier (10), Stéphane
Ederhy (11), Nicolas Lamblin (12), Olivier Varenne (13), Vincent Probst (14),
François Aupetit (15), Olivier Dubourg (16)
(1) Hôpital Ambroise Paré, Service de Cardiologie, Boulogne, France –
(2) CHU Haut-Lévêque, Bordeaux, Pessac, France – (3) CHU Pasteur,
Nice, France – (4) Hôpital Nord, Marseille, France – (5) CHU Rennes –
Hôpital Pontchailloux, Rennes, France – (6) CHU Gabriel Montpied,
Clermont-Ferrand, France – (7) CH Compiègne, Compiègne, France –
(8) Hôpital Bichat-Claude Bernard, Paris, France – (9) CH Le-Raincy-
Montfermeil, Montfermeil, France – (10) CHU d'Amiens Sud, Amiens,
France – (11) Hôpital Saint Antoine, Paris, France – (12) CHRU Lille,
Lille, France – (13) Hôpital Cochin, Paris, France – (14) CHU Laënnec,
Nantes , France – (15) CH Saint Joseph – Saint Luc, Lyon, France –
(16) Hôpital Ambroise Paré, Boulogne, France
Background: Tako-Tsubo cardiomyopathy (TTC) is a stress-induced car-
diomyopathy and is characterized by transient left ventricular (LV) dysfunc-
tion. The aim of this prospective study was to assess patient personality
presenting with TTC with a stress scale.
Methods: The study population included 300 patients: 100 presenting with
TTC (95 women, 71±12 y.o.) and 2 age and sex-matched control groups
(100 patients presenting with acute coronary syndrome [ACS] and 100 patients
undergoing an orthopaedic surgery). TTC was defined according to the Mayo-
Clinic criteria and no patient from the control groups had a TTC or a previous
history of TTC. All patients had an assessment of their status of anxiety and
depression using the Hospital Anxiety and Depression (HAD) scale: maximal
global score is 42 and anxiety and depression may be separately assessed.
Results: Among TTC, a typical pattern was observed in 73 pts, an apical-
sparing variant in 16 pts and an inverted TTC in 1 patient. The mean HAD
scale was 14.7±6.6 in TTC versus 12.25±6.3 in surgical group (p=0.009), but
no significant difference was observed with ACS group (p=0.70), as expected
(announce of coronary artery disease). In 38 patients with a precipitating
factor in the hours before TTC, no difference was observed concerning the
global HAD scale. Interestingly, depression scale was significantly higher in
patients without precipitating factor in the hours before TTC (5.9±3.8 versus
4.4±3.4 in patients with precipitating factor, p=0.04).
Conclusion: Our prospective study suggests that patients presenting with
TTC are more stressed as compared to patients with orthopaedic surgery.
Depression personality is more important in TTC patients without precipi-
tating stress factor.
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The prognostic value of albumin during acute heart failure: a predic-
tive biomarker of mortality
Ahmed Hamzaoui (1), Hamdi Sonia (2), Chakroun Mahdi (3), Walid
Jomaa (2), Ben Hamda Kholdoun (4), Matouk Faouzi (2), Mohssen
Hssine (1)
(1) CHU Fattouma Bourguiba Monastir, Hématologie biologique et
banque du sang, Monastir, Tunisie – (2) CHU Fattouma Bourguiba
Monastir, Cardiologie, Monastir, Tunisie – (3) Faculté de médecine Sfax
CHU Fattouma Bourguiba Monastir, Cardiologie, Monastir, Tunisie –
(4) Faculté de Monastir CHU Fattouma Bourguiba Monastir, Cardio-
logie, Monastir, Tunisie – 
Background: acute heart failure carries high mortality rates, many bio-
logical markers may help to identify the mortality risk.
Goal: to evaluate retrospectively the prognostic relevance of serum
albumin in patients with acute heart failure. 
Methods: Usual variables were collected in 234 patients aged 65±14 years
with acute heart failure. Serum albumin was determinate after the admission
and in the phase of stabilization. Only 181 patients (77.35%) have albumia
value collected.
Results: Hypoalbuminemia was a common state in patients with heart
failure, observed in 87%. It was related to the malnutrition in 52%. Hospital
mortality rate was 11.25%. Patients who died have similar age, serum haemo-
globin and left ventricular ejection fraction with patients who survived. But,
albuminia and BNP predicted this evolution in multivariate models, however
other biomarkers like CRP, Troponine I no longer predicted outcome. Serum
albumin was the best independent predictor of hospital death, with blood urea
nitrogen, HbA1c and BNP. 
Conclusion: Along with diastolic dysfunction, one to several cardiovascular
or general aggravating factors are still found in acute heart failure with pre-
served systolic function and should be systematically sought. Hypoalbuminemia
is a common condition in patients with heart failure and is mainly related to the
malnutrition-inflammation complex syndrome. Other causal factors can be
observed, which include hemodilution, liver dysfunction, renal and enteral loss.
BNP and serum albumin offer additional information for the mortality pre-
diction in patient with acute heart failure and deserves further attention in mul-
timarker strategies.
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Effects of hypoxia, exercise and sildenafil and their interactions on
cardiac and vascular function in patients with chronic heart failure.
Thibaud Damy (1), James Hobkirk (2), Mandy Walters (2), Alan Rigby (3),
Jean-Luc Dubois-Randé (1), Luc Hittinger (1), Andrew Clark (2), John Gf
Cleland (2)
(1) CHU Henri Mondor, Fédération de Cardiologie, Créteil, France –
(2) NHS trust East Yorkshire, Academic Cardiology, Cottingham,
Royaume-Uni – (3) Castle Hill Hospital, Academic Cardiology, Kingston-
Upon-Hull, Royaume-Uni
Background: Pulmonary hypertension is an adverse prognostic sign in heart
failure but little attention has been paid to either mechanisms or management. 
Objective: Investigate the effects of physiological (exercise and hypoxia)
and pharmacological (sildenafil) interventions and their interactions on cardio-
vascular function in patients with chronic heart failure in a factorial rando-
mized trial.
Methods: Eighteen patients were studied, at rest and during semi-recumbent
bicycle exercise at 25 watts, 75 minutes after Sildenafil (2x20mg) or placebo
(double-blind) while breathing air or 15% oxygen (single-blind) on four separate
days. Transcutaneous oxygen saturation, blood pressure (BP), systemic vascular
resistance (SVR) and cardiac output (CO) were measured non-invasively
(Nexfin). Left and right ventricular (RV) systolic and diastolic function and RV
tricuspid pressure gradient (RVTG) were measured echocardiographically.
Results: At rest, oxygen saturation fell while breathing 15% oxygen and
RVTG increased from 23.6±8.7mmHg by 4.6±4.0mmHg (p<0.001). Exercise
increased RVTG by 19.2±11.3 (p<0.0001) but this was not exacerbated by
hypoxia. At rest, sildenafil caused small falls in oxygen saturation, SVR and
RVTG and reversed hypoxia-induced increases in systolic BP and RVTG.
During exercise on air, sildenafil did not reduce increases in RVTG but,
during hypoxia, reduced SVR, increased CO and may have blunted further
increases in RVTG. 
Conclusion: In patients with chronic heart failure, hypoxia and exercise both
cause a rise in RVTG. Sildenafil reduces RVTG at rest and reverses the rise
caused by hypoxia but not that induced by exercise. This might be a useful
model to investigate interventions for pulmonary hypertension in heart failure.
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Left atrial remodeling at rest predicts an increase in left ventricular
filling pressure upon effort
Nadjib Hammoudi, Marc Achkar, Florent Laveau, Lila Boubrit, Jean
Baptiste Vignalou, Aude Brucker, Morad Djebbar, Yann Allali, Michel
Komajda, Pierre Louis Michel, Richard Isnard
Hôpital de La Pitié-Salpêtrière, Cardiologie, Paris, France
Purpose: Undiagnosed dyspnea after routine work-up is far from being
exceptional. Suspected latent heart failure with preserved ejection fraction
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(HFPEF) at rest could be revealed in a number of patients upon effort, but
stress testing cannot be performed systematically. E/e’ ratio is linked to inva-
sive measurement of left ventricle (LV) filling pressure (LVFP) at exercise,
and exercise E/e’ > 13 has been proposed to diagnose increasing LVFP. 
Hypothesis: Considering left atrial (LA) remodeling as the “glycated
hemoglobin” of chronic elevation of LVFP, we believe that LA volume at rest
can predict an increase in LVFP upon effort. 
Method: 74 stable patients (59.2±11.3 years, 58 men) with normal LV
ejection fraction (EF) and in sinus rhythm underwent exercise echocardiog-
raphy for clinical indications. LA volume by biplane method and indexed to
body surface area (LAi), LVEF, pulmonary pressure by tricuspid regurgitation
(TR), and LVFP at rest (E/e’) and at exercise were measured. Exercise E/e’> 13
was used as a threshold to define elevated LVFP at exercise. 
Results: In univariate analysis, patients who had an increase in E/E’ upon
effort are older and have a larger LAi and a higher E/E’ at rest (table). 
In multivariate analysis, LAi and E/E’ independently determine an increase
in LVFP upon effort. 
Rest LAVi > 34ml/m² predicts an exercise E/e’>13 response with 75% sen-
sitivity and 82% specificity according to ROC analysis (AUC 0.80). 
Conclusion: Left atrial volume at rest seems to be an interesting tool to
predict an increase in left ventricule filling pressure in patients with normal
left ventricle ejection fraction.
Table. Results
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The risk of heart failure in Tunisian patients with type 2 diabetes
treated with oral agent monotherapy.
Ahmed Hamzaoui (1), Hamdi Sonia (2), Chakroun Mahdi (3), Walid
Jomaa (2), Ben Hamda Kholdoun (4), Fadwa Hssine (5), Ilhem Hellara (5),
Mohssen Hssine (1), Mohamed Fadhel Najjar (5), Matouk Faouzi (2)
(1)CHU Fattouma Bourguiba Monastir, Service d’hématologie biologique
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Aim: To determine if the risk of developing heart failure (HF) is associated
with the use of sulfonylurea or metformin in patients with diabetes.
Methods: Retrospective cohort study of all adults without HF newly
treated with oral antidiabetic drugs in fattouma bourguiba monastir hospital,
Tunisia between 2000 and 2011.
Results: Of 224 diabetic subjects (mean age 65±13years) newly treated
with a single oral agent and followed for 4.7 (±2.2) years, 181 developed HF.
The incidence of HF was greater in patients using sulfonylurea monotherapy
(123 cases; 67.95%) than those taking metformin monotherapy (58 cases,
32.05%), and users of high-dose sulfonylureas presented more risk to develop
incident HF than users of high-dose metformin. Users of high-dose sulfo-
nylureas were also more likely to develop HF than users of low-dose sulfo-
nylureas; no such association existed for metformin users
Conclusions: Users of higher doses of sulfonylurea exhibited a greater risk
of developing HF. Clinicians should carefully weigh the need for high-dose
sulfonylurea therapy in diabetic subjects with, or at high risk of, HF.
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Epidemiology profile, management and development of 1800 patients
with chronic heart failure
Fatima Wadrahmane, Roger Kokusa
CHU Ibn Rochd Casablanca, Cardiologie, Casablanca, Maroc
Introduction: Heart failure (HF) remains a frequent admission and read-
mission to the hospital grounds and therefore represents a major problem of
public health. The aim of our study was to report the experience of our treat-
ment of heart failure unit (UTIC), the epidemiological profile, management
and evolution of 1800 patients with chronic heart failure.
Materials and methods: The study included 1,800 patients admitted to the
heart failure unit from May 2009 to February 2013. We included all sympto-
matic patients with class II, III or IV efforts, with or without signs of heart
failure, regardless of LV ejection fraction.
Statistical analysis was performed using Epi-Info 6.0 fr. The chi2 test was
used. A difference was considered statistically significant if p <0.05. 
Results: The average age of our patients was 64.82±12.14 years (16-100),
with a male predominance (65% vs. 35%). Hypertension was the most
common factor (26%) cardiovascular risk, followed by smoking (22%) and
diabetes (21%). Patients were mainly NYHA class II (58%), and 27% were in
NYHA class III. The average 6min walk test was 121.36±92.74 m (10-
630). The average heart rate at admission was 81.13±17.24 bpm, 87.83% of
patients had a heart rate> 80 bpm. More than half of our patients had an LVEF
<35% (56.91%), . Coronary angiography was performed in 14.25% of
patients.
About the treatment; 89.08% were receiving ACE inhibitors, 78.33% as
beta-blockers, spironolactone in 50.75% and 12.75% on diuretics. Resynchro-
nization was performed in ten patients.
Optimal medical therapy resulted in a significant improvement in NYHA
functional class: Class II (20% vs 58%, P=0.037), class III (5% vs. 27%,
P=0.002), a significant improvement in test 6min walk (465.66 vs. 121.36 m,
P=0.0001) and a significant reduction in heart rate (bpm 63.12bpm vs 80.13,
P <0.05) for an average of 6.82±4.18 month.
Conclusion: Heart failure is the cause of 5% of hospitalizations, creating
a therapeutic unit of heart failure in our department has improved the quality
of care, treatment optimization with better adherence to international recom-
mendations.
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Heart failure patients “relatives” perception of therapeutic education
Laure Garbacz (1), Yves Juillière (2), François Alla (3), Patrick Jourdain (4),
Henry Coudane (5), Christian Hervé (6), Frédérique Claudot (5)
(1) Faculté de Médecine de Nancy, EA 7299, Vandoeuvre Les Nancy, France
– (2) Département de Cardiologie Médicale, Nancy, France – (3) Université
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Aim: Therapeutic patient education (TPE) seems to be comprehensive care
provided to the patient that introduces TPE to new stakeholders such as the
patient’s family. Our survey aimed at understanding relatives’ perception of
TPE and measuring its impact on their daily lives. 
Exercise E/e’ ≤13
(n=66)
Exercise E/e’ >13
(n=8)
p
Age (years) 58.1±11.3 68.5±7.2 0.01
Male n (%) 51 (77.3) 7 (87.5) 0.51
Rest heart rate (beats/
min)
68.9±12.5 60.8±10.0 0.08
Rest systolic blood 
pressure (mmHg)
138.7±19.6 146.8±9.5 0.26
Exercise capacity (watts) 114.6±39.5 93.8±25.9 0.15
LV ejection fraction (%) 66.2±5.6 66.4±10.0 0.92
LAi (ml/m²) 28.7±8.4 35.6±5.1 0.025
E/E’ at rest 9.1±2.8 12.2±2.4 0.004
Tricuspid regurgitation 
velocity (m/s)
2.3±0.2 2.3±0.3 0.78
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Methodology: An auto-administered survey was conducted between
January and May 2013. We addressed the survey to relatives of patients listed
in the ODIN registry created to get a closer look at the mortality of educated
and non educated patients.  A total of 2153 questionnaires were distributed
and permitting anonymous answers.
Results: In May 2013, we received 149 answers. In 51.1% of the cases,
heart failure patients relatives’, aged 62 years old on average (sd. 14.1) were
the patient’s spouse (38.9%), their daughter or son (7.4%) of their brother/
sister (2%). In 21.5% of the cases, they wished to attend therapeutic sessions
with their patient in order to get a clearer understanding of the sickness. They
had witnessed an evolution in their daily lives (32.9%), noting that they
acquired a healthier lifestyle (18.8%) and regained peace in their families’
daily life (6.7%). They said they had changed their lifestyle in 34.2% of the
cases, especially the quality of food (30.9%).
Conclusion: Following the TPE program, advice relevant to lifestyle habits
were given by healthcare professionals to patients and their relatives who have
participated in the sessions. They saw an evolution in their lifestyles and
acquired a healthier routine especially in terms of food and physical activity.
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BNP absolute value but not 6 month BNP variation is a powerful pro-
gnostic marker in a prospective systolic heart failure follow up.
Patrick Jourdain (1), Natalya Hrynchyshyn (1), Francois Funck (2), Yves
Juillière (3), Gerald Roul (4), Joel Dagorn (1), Michel Desnos (6)
(1)CH René Dubos, UT d’insuffisance cardiaque, Pontoise, France –
(2) CH René Dubos, Service de Cardiologie, Pontoise, France – (3)
Nancy University Hospital, Department of Cardiology, Vandoeuvre-
Lès-Nancy, France – (4) CHU Strasbourg, Service de Cardiologie, Stras-
bourg, France – (5) Hôpital Européen Georges Pompidou (HEGP),
Paris, France
BNP is recognized as a powerful prognostic marker in CHF. In acute heart
failure, a decrease of BNP is associate with a better short time prognostic but
in a chronic setting, the respective prognostic performance of absolute value
or 6 month Bnp variation are not yet determined.
We have analyzed BNP in a prospective cohort of 1310 patients with sys-
tolic heart failure. Mean follow up was  52 months . 3287 medical examina-
tions pairs were finally  analyzed.Our patients were mostly male (70%) and
young ( Age 63 years old (15-96), 70% were in sinus rhythm, 10% demon-
strate clinical congestion (lower limb oedema).  Mean LVEF was 36%
(±10). Mean BNP was 424 (±200) pg/ml. During follow up 387 events
(death or HF hospitalizations).BNP demonstrate a linear association with the
risk of death or rehospitalisation for HF. BNP <50 pg/ml regardless of
LVEF was associated with a risk of events lower than 5% in the next
6 months.  The 6 month increase respectively to 7, 11, 20 and 27% for BNP
plasma level of 100, 200, 500 or 1000 pg/ml. According to tiertiles we have
analysed the impact of a BNP variation (>30%). BNP variation is associated
to a prognostic hange only if initial BNP is higher than 500 pg/ml and not
if the BNP is lower than this cut off.
Conclusion: In systolic heart failure patients follow up, BNP absolute
value is a powerful prognostic marker but BNP variation between two sam-
pling is not, unless BNP is higher than 500 pg/ml.
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Takotsubo cardiomyopathy: the experience of the cardiology depart-
ment of Nancy, France.
Frédéric Moulin, Zied Frikha, Batric Popovic, Simon Lemoine, Sylvain
Carillo, Etienne Aliot, Michael Angioi, Olivier Huttin
CHU Brabois, Département de Cardiologie, Vandoeuvre Les Nancy, France
Background: Takotsubo cardiomyopathy (TC) is a transient form of acute
heart failure triggered by stressful events. We present a single centre experi-
ence of TC with long term follow-up.
Methods: Fifty-six consecutive patients presenting with a diagnostic of TC
hospitalized in our center between January 2002 and January 2013 were
included. Demographic characteristics, clinical features, angiographic results,
echocardiograms and cardiac magnetic resonance (CMR) findings and out-
comes were analysed.
Results: Eighty-nine percent of patients (n=50) were postmenopausal
women, 3.5% (n=2) were younger women  (<50 years), and 7.1% (n=4) were
men. Hypertension was the most common risk factor for coronary heart dis-
ease (68%). A stressful trigger was identified in 40 patients (71.4%). Chest
pain was the most common symptom (73%). Only one patient presented car-
diac arrest at admission. ST-segment elevation (61%) and global T wave
inversion (48%) were the most frequent electrocardiogram changes. The peak
troponin levels was 4.98±5.24 ng/ml. Left ventricular assessment demon-
strated typical apical ballooning in 42 patients and midventricular variant in
14 patients. Left ventricular ejection fraction (LVEF) was reduced
(39.51±9.18%) in all patients. CMR was performed at 6.7±6.8 days after
admission and confirmed TC with absence of myocardial necrosis in all
patients. In-hospital complications occured in 13 patients (23.2%) and
included acute pulmonary oedema (n=5), cardiogenic shock (n=3), death
(n=3), left ventricular thrombus (n=1) and atrial fibrillation (n=1). After a
mean follow-up of 49±30.28 months, the mean LVEF increased to
55.48±19.05%. Overall mortality and recurence were noted respectively in
3.57% and 1.78% of cases. 
Conclusion: Our study demonstrated that although TC is a reversible form
of acute heart failure with low rate of recurrence at long-term follow-up, it is
associated with significant in-hospital morbidity and mortality in a proportion
of patients.
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Prevalence of differential diagnoses in a population with suspected
Takotsubo cardiomyopathy
Clement Delmas, Caroline Biendel – Piquet, Meyer Elbaz, Didier Carrie,
Michel Galinier, Olivier Lairez
CHU Rangueil, Fédération des services de cardiologie, Toulouse, France
Background: Takotsubo cardiomyopathy (TTC) is a recently reco-
gnized entity, which should be considered in suspected acute coronary
syndrome. Diagnostic criteria exist since 2004, but there is currently no
recommendation of learned societies as the minimum balance required for
its diagnosis. The exponential increase of the number of TTC diagnoses
assumes the risk of misdiagnosis and thus the risk of delayed appropriate
management. 
Aim: Determine the prevalence of differential diagnosis in a “real life”
population of patient with suspected TTC.
Methods and results: Between October 2009 and March 2012, 3375 patients
were admitted for acute coronary syndrome with troponin elevation in our
Department of Cardiology. Among them 70 (2.1%) patients were sus-
pected for TTC and were included in a prospective cohort. According to
the initial presentation, these patients were explored by cardiac MRI, mea-
surement of urinary and/or plasma catecholamines and thyroid balance.
Among the 70 initially suspected TTC, 9 (12.9%) diagnosis and therefore
management were changed after the completed assessment. Four (5.7%)
and 3 (4.3%) patients were reclassified as myocarditis and sub-endocardial
infarction by MRI, respectively. For one (1.4%) of them, MRI led to per-
form a methergin test, confirming the diagnosis of spastic angina. For
another one (1.4%), biological test guide to the diagnosis of adrenal pheo-
chromocytoma.
Conclusion: Differential diagnosis in patients with suspected TTC repre-
sents more than 10% of the whole population and need probably to perform a
minimum check-up (figure next page).
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Assessment of Tako-Tsubo cardiomyopathy recovery using 2D strain
echocardiography
Nicolas Mansencal, Maria Arslan, Rami El Mahmoud, Rémy Pillière,
Olivier Dubourg
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Background: Tako-Tsubo cardiomyopathy (TTC) is characterized by tran-
sient stress induced transient left ventricular (LV) dysfunction. The aim of this
study was to assess LV involvement in TTC by 2D speckle tracking echocar-
diography.
Methods: We prospectively studied 40 pts presenting with typical pattern
of TTC. All patients underwent 3 echocardiographic examinations: at admis-
sion, at day 5 and at one-month follow-up. The diagnosis of TTC was defined
according to Mayo Clinic criteria. We used the Automated Function Imaging
(AFI) in apical 2-, 3- and 4- chamber views, allowing to calculate longitudinal
global strain, strain of each left ventricular segment and the bull’s-eye display.
This AFI method non-invasively tracks and calculates peak systolic strain
based on 2D strain.
Results: Mean age was 70±10 y.o. (95% of women). Longitudinal global
strain (LGS) was significantly depressed at admission as compared to LGS
calculated at day 5 and at one-month follow-up (–6±2% versus –10±4% at day
5 versus –20±3% at one-month follow-up, p< 0.0001). At admission, strain
was particularly depressed in median and apical left ventricular segments and
this dysfunction was circular (–2±1% versus –10±2% in basal segments). At
day 5, partial recovery was observed, particularly in middle lateral and inferior
walls, with an asymmetrical dysfunction. At one-month follow-up, a complete
recovery of LGS was observed in all left ventricular walls (–20±3%).
Conclusion: Our study suggests that left ventricular systolic dysfunction is
circular and may be assessed by 2D strain. Recovery is asymmetrical and is
complete at one-month follow-up.
Standard paraclinical
screening (coronarography,
echocardiography, BNP,
troponin,...)
1. Cardiac MRI
2. Plasmatic and urinary
 catecholamin
3. Thyroid balance
61 real TTC
3375
ACS patients with
troponin elevation
70 TTC like
syndrome
· 4 Myocarditis
· 4 ACS (3 MI et 1 Spastic MI)
· 1 Pheochromocytoma
· 91 Myocarditis
· 3214 ACS
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